NovoCure

$199.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.62 (+2.37%) As of 5:02 PM UTC today

Why Robinhood?

You can buy or sell NovoCure and other stocks, options, and ETFs commission-free!

About NVCR

NovoCure Limited Ordinary Shares, also called NovoCure, is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St.

CEO
Asaf Danziger
Employees
1,023
Headquarters
St. Helier, Jersey
Founded
2000
Market Cap
21.28B
Price-Earnings Ratio
1.05K
Dividend Yield
—
Average Volume
2.66M
High Today
$203.22
Low Today
$193.04
Open Price
$194.83
Volume
590.48K
52 Week High
$218.09
52 Week Low
$55.40

NVCR Earnings

-$0.05
$0.01
$0.06
$0.12
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 29, Pre-Market

You May Also Like

ILTB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure